Hookipa Pharma jumps 40% after FDA approval of clinical tests [MarketWatch]
HOOKIPA Pharma Inc. (HOOK)
Last hookipa pharma inc. earnings: 3/19 07:00 am
Check Earnings Report
Company Research
Source: MarketWatch
Hookipa Pharma jumps 40% after FDA approval of clinical tests Hookipa Pharma Inc. HOOK, -2.34% shares jumped 40% in late trading Thursday after the company announced that the Food and Drug Administration approved a study of the company's immunotherapy approach to certain cancers. Hookipa had asked the FDA for clearance on a phase 1/2 study of HB-201, and with its approval will now start its first clinical trial in immuno-oncology, the company said. "With the FDA's clearance of our IND application we have achieved an important milestone advancing HB-201 into clinical development," Chief Executive Joern Aldag said in the announcement. Hookipa, which went public in April , closed Thursday at $6.68, but shares neared $9.50 in after-hours trading following the announcement.
Show less
Read more
Impact Snapshot
Event Time:
HOOK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HOOK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HOOK alerts
High impacting HOOKIPA Pharma Inc. news events
Weekly update
A roundup of the hottest topics
HOOK
News
- HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to RegistrationGlobeNewswire
- Hookipa Pharma Inc (NASDAQ: HOOK) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $5.00 price target on the stock.MarketBeat
- Hookipa Pharma Inc (NASDAQ: HOOK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.50 price target on the stock.MarketBeat
HOOK
Earnings
- 3/22/24 - Miss
HOOK
Sec Filings
- 4/17/24 - Form 4
- 4/17/24 - Form 4
- 4/17/24 - Form 4
- HOOK's page on the SEC website